Skip to main content
. 2005 May 9;102(21):7647–7652. doi: 10.1073/pnas.0408531102

Table 1. Cytokine profile after long dsRNA or siRNA treatment.

Treatment GM-CSF* IL-1α MCP-1 IL-2 IL-6 IL-12p70 IFN-γ IL-18 GRO/KC
Naïve <24.5 <24.5 173.3 ± 63.8 <24.5 <24.5 <24.5 <24.5 186.3 ± 88.4 221.5 ± 49.7
dsControl <24.5 <24.5 212.0 ± 37.8 75.0 ± 67.3 32.5 ± 1.1 <24.5 61.3 ± 44.6 568.9 ± 476.1 224.5 ± 124.2
dsCRF <24.5 58.7 ± 45.6 171.3 ± 41.2 42.5 ± 12.0 300.8 ± 184.2 37.2 ± 16.9 117.5 ± 62.0 114.5 ± 65.0 223.8 ± 109.6
dsUcnII <24.5 43.3 ± 25.1 155.2 ± 26.1 <24.5 46.2 ± 28.9 38.3 ± 18.4 90.7 ± 76.6 66.0 ± 30.7 115.5 ± 45.7
siCRF <24.5 259.4 ± 236.8 284.5 ± 61.0 46.9 ± 28.3 439.3 ± 375.8 32.5 ± 9.3 131.4 ± 54.6 311.3 ± 92.5 254.3 ± 49.6
siControl <24.5 <24.5 212.0 ± 28.7 28.8 ± 0.4 32.5 ± 10.7 <24.5 25.7 ± 1.6 243.3 ± 113.1 225.3 ± 52.4

Cytokine concentrations in basal plasma sample were measured (pg/ml). Long dsRNA or siRNA treatment had either no effect or a similar effect on cytokine levels (±SEM). si, small interfering; MCP, monocyte chemotatic protein 1; GRO/KC; KC is a chemokine and GROα is the murine homologue.

*

Levels of 8 of 14 cytokines (GM-CSF, IL-1β, IL-4, IL-5, IL-10, IL-12p70, and TNF-α) were within normal (basal) range (<24.5 pg/ml).